Hope and anxiety surround new Alzheimer’s drug lecanemab

2 pharmaceutical firms state a medication they’ve created has the prospective to reduce the progression of Alzheimer’s, something no treatment has been able to do. Now, scientists and those affected by the illness are anxiously waiting for the full results of a human trial for the medicine.

#alzheimers #treatment #healthcare

View The National survive on YouTube Sunday-Friday at 9 p.m. ET

Subscribe to The National:
https://www.youtube.com/user/CBCTheNational?sub_confirmation=1

Get in touch with The National online:
Facebook|https://www.facebook.com/thenational
Twitter|https://twitter.com/CBCTheNational
Instagram|https://www.instagram.com/cbcthenational

Much More from CBC News|https://www.cbc.ca/news

The National is the flagship of CBC News, showcasing prize-winning journalism from throughout Canada and also worldwide. Led by Chief Correspondent Adrienne Arsenault as well as Ian Hanomansing, our team of relied on reporters help you make feeling of the globe, anywhere you are. The National was called Canada’s Best National Newscast by the Canadian Screen Awards as well as RTDNA Canada.